Preface
Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies
Translational Lung Cancer Research
2017;
6
(2)
:109-112
.
(27 April 2017)
Review Article
Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer
Translational Lung Cancer Research
2017;
6
(2)
:113-118
.
(27 April 2017)
Special topics in immunotherapy and radiation therapy: reirradiation and palliation
Translational Lung Cancer Research
2017;
6
(2)
:119-130
.
(27 April 2017)
Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy
Translational Lung Cancer Research
2017;
6
(2)
:131-147
.
(27 April 2017)
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Translational Lung Cancer Research
2017;
6
(2)
:148-158
.
(27 April 2017)
Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)
Translational Lung Cancer Research
2017;
6
(2)
:159-168
.
(27 April 2017)
Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma
Translational Lung Cancer Research
2017;
6
(2)
:169-177
.
(27 April 2017)
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer
Translational Lung Cancer Research
2017;
6
(2)
:178-185
.
(27 April 2017)
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Translational Lung Cancer Research
2017;
6
(2)
:186-195
.
(27 April 2017)
Current state of immunotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2017;
6
(2)
:196-211
.
(27 April 2017)
Immunotherapy and radiation therapy for malignant pleural mesothelioma
Translational Lung Cancer Research
2017;
6
(2)
:212-219
.
(27 April 2017)
Mini-Review
Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2017;
6
(2)
:220-229
.
(27 April 2017)
Controversies on Lung Cancer: Pros and Cons2
Pros: the present classification of mucinous adenocarcinomas of the lung
Translational Lung Cancer Research
2017;
6
(2)
:230-233
.
(27 April 2017)
Cons: the confusing mucinous adenocarcinoma classification
Translational Lung Cancer Research
2017;
6
(2)
:234-240
.
(27 April 2017)
Rebuttal from Professor Sanja Dacic
Translational Lung Cancer Research
2017;
6
(2)
:241-242
.
(27 April 2017)
Rebuttal from Professor Helmut H. Popper
Translational Lung Cancer Research
2017;
6
(2)
:243-245
.
(27 April 2017)
Disclosure:
1. The focused issue “Combining Radiation Therapy and Immunotherapy for Thoracic Malignancies” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Charles B. Simone II, Abigail T. Berman and Salma K. Jabbour served as the unpaid Guest Editors for the focused issue.
2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
